EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Quantification of Low-Level Crystalline Impurities in Dalmelitinib Mesylate Using NIR Spectroscopy and Chemometric Modeling

Runxi Gui, Xiaogang Lian, Maolin Li, Mingdi Liu, Lina Zhou, Songgu Wu, Qiuxiang Yin

Separations · 09.06.2026 · 13 (6) · 170

DOI: 10.3390/separations13060170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Separations, online erschienen am 09.06.2026. Verfasst von Runxi Gui und 6 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Government-Guided Local Science and Technology Development Fund Project, Special Project for High-Level Talent Team Construction in Hebei Provincial Science and Technology Plan, Tianjin Youth Science and Technology Talent Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate measurement and control of impurities are critical for ensuring the quality and therapeutic performance of solid-state pharmaceutical formulations. This study introduces a rapid, minimal sample preparation analytical approach for quantifying low-level dalmelitinib impurities in dalmelitinib mesylate, employing near-infrared (NIR) spectroscopy combined with partial least squares regression (PLSR). To mimic actual manufacturing conditions, a mixture system was designed comprising dalmelitinib mesylate, dalmelitinib impurity, and formulation excipients. Various spectral preprocessing strategies were systematically evaluated, including Savitzky–Golay first derivative (SG1st), Savitzky–Golay second derivative (SG2nd), multiplicative scatter correction (MSC), standard normal variate (SNV), wavelet denoising, wavelet compression, and their combinations. The optimal model was obtained using SG1st combined with wavelet denoising. The resulting PLSR model (7 latent variables) showed good predictive performance, with an R2 of 0.99569 and an RMSECV of 0.00315. The limit of detection (LOD) and limit of quantification (LOQ) were 0.234% and 0.708%, respectively, demonstrating applicability for monitoring low-level impurities in pharmaceutical formulations. Method validation demonstrated satisfactory precision (RSD < 3%), accuracy (100.77–102.01%), and stability over 24 h (RSD ≤ 4.75%). Compared with conventional solid-state analytical techniques, the proposed NIR–PLSR framework enables rapid, non-destructive analysis with minimal sample preparation. The combination of derivative preprocessing and wavelet denoising improved extraction of impurity-related spectral information in complex pharmaceutical systems, highlighting the potential of this approach for process analytical technology (PAT) and pharmaceutical quality monitoring.

Förderung

  • Central Government-Guided Local Science and Technology Development Fund Project
  • Special Project for High-Level Talent Team Construction in Hebei Provincial Science and Technology Plan
  • Tianjin Youth Science and Technology Talent Project
  • Tianjin Natural Science Foundation

Zitieren

APA

Gui, R., Lian, X., Li, M., Liu, M., Zhou, L., Wu, S., & Yin, Q. (2026). Rapid Quantification of Low-Level Crystalline Impurities in Dalmelitinib Mesylate Using NIR Spectroscopy and Chemometric Modeling. Separations, 13(6), 170. https://doi.org/10.3390/separations13060170

Vancouver

Gui R, Lian X, Li M, Liu M, Zhou L, Wu S, et al. Rapid Quantification of Low-Level Crystalline Impurities in Dalmelitinib Mesylate Using NIR Spectroscopy and Chemometric Modeling. Separations. 2026;13(6):170. doi:10.3390/separations13060170

BibTeX
@article{Gui2026,
  author = {Gui, Runxi and Lian, Xiaogang and Li, Maolin and Liu, Mingdi and Zhou, Lina and Wu, Songgu and Yin, Qiuxiang},
  title = {Rapid Quantification of Low-Level Crystalline Impurities in Dalmelitinib Mesylate Using NIR Spectroscopy and Chemometric Modeling},
  journal = {Separations},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {170},
  doi = {10.3390/separations13060170}
}
Kostenlos starten →